LEVOCETIRIZINE DIHYDROCHLORIDE

LEVOCETIRIZINE DIHYDROCHLORIDE was reported 24411 times

These side effects are most commonly reported by patients taking LEVOCETIRIZINE DIHYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 3142
1 SOMNOLENCE 2163
2 FATIGUE 1780
3 HEADACHE 1426
4 PRURITUS 1357
5 NAUSEA 1177
6 DYSPNOEA 1152
7 DIARRHOEA 1087
8 DIZZINESS 966
9 COUGH 867
10 RASH 833
11 ARTHRALGIA 831
12 INSOMNIA 796
13 OFF LABEL USE 787
14 PAIN 776
15 PYREXIA 739
16 MALAISE 737
17 VOMITING 676
18 FALL 645
19 FEELING ABNORMAL 607
20 URTICARIA 594
21 ASTHENIA 580
22 PRODUCT DOSE OMISSION ISSUE 576
23 SINUSITIS 557
24 HYPERSENSITIVITY 534
25 PRODUCT USE IN UNAPPROVED INDICATION 507
26 NO ADVERSE EVENT 506
27 PNEUMONIA 490
28 ASTHMA 483
29 CONDITION AGGRAVATED 480
30 COVID-19 480
31 ABDOMINAL PAIN 469
32 DECREASED APPETITE 459
33 ABDOMINAL PAIN UPPER 453
34 BLOOD PRESSURE INCREASED 435
35 ANXIETY 430
36 INJECTION SITE PAIN 423
37 MYALGIA 409
38 CHILLS 395
39 THERAPEUTIC RESPONSE DECREASED 395
40 SEPSIS 352
41 CONSTIPATION 351
42 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 347
43 VISION BLURRED 343
44 ERYTHEMA 342
45 EYE PAIN 341
46 BACK PAIN 338
47 PAIN IN EXTREMITY 337
48 NASOPHARYNGITIS 333
49 RHINORRHOEA 331
50 WEIGHT INCREASED 329
51 TACHYCARDIA 328
52 PRODUCT USE ISSUE 324
53 DEPRESSION 323
54 ALTERED STATE OF CONSCIOUSNESS 321
55 WEIGHT DECREASED 319
56 DRY SKIN 318
57 ILLNESS 307
58 URINARY TRACT INFECTION 306
59 HAEMORRHAGIC STROKE 305
60 MUSCLE SPASMS 282
61 CARDIO-RESPIRATORY ARREST 281
62 NASAL CONGESTION 278
63 SYNCOPE 278
64 HEAD DISCOMFORT 270
65 BRONCHITIS 269
66 TINNITUS 257
67 DERMATITIS ATOPIC 256
68 DRUG HYPERSENSITIVITY 254
69 OROPHARYNGEAL PAIN 254
70 ANAEMIA 250
71 BLINDNESS 247
72 MIGRAINE 246
73 OCULAR DISCOMFORT 246
74 ABDOMINAL DISCOMFORT 242
75 COMA 241
76 ASCITES 239
77 DRY MOUTH 239
78 HAEMATEMESIS 237
79 INFECTION 237
80 CHEST PAIN 232
81 PRESYNCOPE 230
82 PERIPHERAL SWELLING 229
83 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 229
84 HYPERTENSION 227
85 AMAUROSIS FUGAX 226
86 LOSS OF CONSCIOUSNESS 223
87 GAIT DISTURBANCE 220
88 PALPITATIONS 220
89 ALOPECIA 217
90 GENERALISED OEDEMA 216
91 INFLUENZA 215
92 PARAESTHESIA 215
93 HAEMATURIA 213
94 CHEST DISCOMFORT 208
95 DEATH 208
96 DIPLOPIA 208
97 EPISTAXIS 208
98 INCORRECT DOSE ADMINISTERED 206
99 SKIN EXFOLIATION 205
100 SNEEZING 202
101 UPPER RESPIRATORY TRACT INFECTION 200
102 URINARY TRACT DISORDER 194
103 HYPOAESTHESIA 191
104 DRUG INTERACTION 190
105 EYE PRURITUS 187
106 ECZEMA 186
107 OEDEMA PERIPHERAL 186
108 THERAPEUTIC RESPONSE SHORTENED 186
109 ANAPHYLACTIC REACTION 184
110 DRY EYE 184
111 PHOTOPHOBIA 184
112 SWELLING 184
113 TREMOR 184
114 CONTUSION 182
115 INTENTIONAL PRODUCT USE ISSUE 182
116 HEART RATE INCREASED 181
117 SLEEP DISORDER 181
118 MEMORY IMPAIRMENT 177
119 DEHYDRATION 175
120 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 174
121 INJECTION SITE ERYTHEMA 171
122 GASTROOESOPHAGEAL REFLUX DISEASE 164
123 SEASONAL ALLERGY 158
124 PLATELET COUNT DECREASED 157
125 ABDOMINAL DISTENSION 155
126 HYPOTENSION 154
127 UNEVALUABLE EVENT 149
128 WHITE BLOOD CELL COUNT DECREASED 149
129 THROAT IRRITATION 148
130 HYPERHIDROSIS 147
131 LACRIMATION INCREASED 147
132 SWELLING FACE 146
133 THERAPEUTIC RESPONSE UNEXPECTED 146
134 MUSCULAR WEAKNESS 145
135 WHEEZING 144
136 DYSPEPSIA 143
137 EAR INFECTION 141
138 INJECTION SITE SWELLING 137
139 ACUTE KIDNEY INJURY 136
140 OVERDOSE 136
141 PSORIASIS 135
142 HOT FLUSH 131
143 SEIZURE 131
144 ARTHRITIS 130
145 EXTRA DOSE ADMINISTERED 130
146 GASTROINTESTINAL DISORDER 129
147 INFUSION RELATED REACTION 129
148 PRODUCT QUALITY ISSUE 129
149 DYSPHAGIA 126
150 HYPERSOMNIA 126
151 VISUAL IMPAIRMENT 126
152 CONFUSIONAL STATE 125
153 HALLUCINATION 125
154 RHEUMATOID ARTHRITIS 125
155 DYSPHONIA 124
156 PRODUCTIVE COUGH 123
157 NIGHTMARE 122
158 SUICIDAL IDEATION 122
159 CHRONIC KIDNEY DISEASE 121
160 FLUSHING 121
161 INTENTIONAL PRODUCT MISUSE 119
162 JOINT SWELLING 119
163 NECK PAIN 118
164 NEUROPATHY PERIPHERAL 116
165 DISCOMFORT 115
166 SURGERY 111
167 ADVERSE DRUG REACTION 110
168 ANGIOEDEMA 109
169 HOSPITALISATION 109
170 RASH PRURITIC 108
171 RENAL IMPAIRMENT 108
172 SINUS DISORDER 108
173 BURNING SENSATION 107
174 DRUG EFFECT LESS THAN EXPECTED 107
175 HERPES ZOSTER 107
176 STRESS 106
177 OCULAR HYPERAEMIA 105
178 BALANCE DISORDER 104
179 BLOOD PRESSURE DECREASED 104
180 VERTIGO 104
181 INFLUENZA LIKE ILLNESS 102
182 INFUSION SITE PAIN 102
183 THROMBOCYTOPENIA 102
184 INJECTION SITE BRUISING 101
185 MUSCULOSKELETAL STIFFNESS 101
186 PULMONARY EMBOLISM 101
187 RENAL FAILURE 99
188 DRUG DOSE OMISSION 98
189 EYE IRRITATION 98
190 IRRITABILITY 98
191 VIRAL INFECTION 98
192 ACCIDENTAL EXPOSURE TO PRODUCT 97
193 ABNORMAL DREAMS 96
194 INFLAMMATION 96
195 RASH ERYTHEMATOUS 96
196 RESPIRATORY TRACT INFECTION 96
197 CATARACT 95
198 GENERAL PHYSICAL HEALTH DETERIORATION 95
199 CELLULITIS 94
200 INSURANCE ISSUE 94
201 DISTURBANCE IN ATTENTION 93
202 INTERSTITIAL LUNG DISEASE 93
203 BLOOD GLUCOSE INCREASED 92
204 MATERNAL EXPOSURE DURING PREGNANCY 91
205 OEDEMA 91
206 SKIN FISSURES 91
207 ATRIAL FIBRILLATION 90
208 FLATULENCE 90
209 INJECTION SITE PRURITUS 89
210 THERAPY INTERRUPTED 89
211 HAEMOGLOBIN DECREASED 88
212 INJECTION SITE REACTION 88
213 PRODUCT DOSE OMISSION IN ERROR 88
214 FEELING HOT 87
215 EMOTIONAL DISTRESS 84
216 LETHARGY 84
217 FLUID RETENTION 83
218 HEREDITARY ANGIOEDEMA 83
219 PHARYNGEAL SWELLING 83
220 DRUG INTOLERANCE 82
221 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 82
222 DISEASE RECURRENCE 81
223 EYE SWELLING 81
224 THERAPEUTIC PRODUCT EFFECT DECREASED 81
225 HEPATIC ENZYME INCREASED 79
226 INFUSION SITE ERYTHEMA 79
227 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 79
228 BLISTER 78
229 INFUSION SITE SWELLING 78
230 OXYGEN SATURATION DECREASED 78
231 STOMATITIS 77
232 DYSGEUSIA 76
233 LYMPHADENOPATHY 76
234 NEPHROLITHIASIS 75
235 UNDERDOSE 75
236 AGITATION 74
237 DIABETES MELLITUS 74
238 EXPOSURE DURING PREGNANCY 74
239 GASTROENTERITIS VIRAL 74
240 INJURY 74
241 LIP SWELLING 73
242 SLEEP APNOEA SYNDROME 73
243 MULTIPLE ALLERGIES 72
244 UPPER-AIRWAY COUGH SYNDROME 72
245 CARDIAC DISORDER 71
246 DERMATITIS CONTACT 71
247 DRUG-INDUCED LIVER INJURY 71
248 DYSURIA 71
249 MOBILITY DECREASED 71
250 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 69
251 OSTEOARTHRITIS 69
252 OSTEOPOROSIS 69
253 POLLAKIURIA 69
254 THROMBOSIS 69
255 ALANINE AMINOTRANSFERASE INCREASED 68
256 MUSCULOSKELETAL PAIN 67
257 PLEURAL EFFUSION 67
258 IMPAIRED QUALITY OF LIFE 66
259 LUNG DISORDER 66
260 ASPARTATE AMINOTRANSFERASE INCREASED 65
261 C-REACTIVE PROTEIN INCREASED 65
262 CEREBROVASCULAR ACCIDENT 65
263 HAEMORRHAGE 65
264 LIMB INJURY 65
265 SYSTEMIC LUPUS ERYTHEMATOSUS 65
266 ANAPHYLACTIC SHOCK 64
267 BONE PAIN 64
268 CARDIAC FAILURE 64
269 DEPRESSED MOOD 64
270 DYSPNOEA EXERTIONAL 64
271 EXPOSURE VIA SKIN CONTACT 64
272 LIVER DISORDER 64
273 FUNGAL INFECTION 63
274 INTENTIONAL DOSE OMISSION 63
275 NEUTROPHIL COUNT DECREASED 63
276 RASH MACULAR 63
277 WITHDRAWAL SYNDROME 63
278 AMNESIA 62
279 ARRHYTHMIA 62
280 DRUG ERUPTION 62
281 NEUTROPENIA 62
282 ADVERSE EVENT 61
283 SINUS CONGESTION 61
284 THERAPY CESSATION 61
285 BLOOD CHOLESTEROL INCREASED 60
286 BLOOD POTASSIUM DECREASED 60
287 FIBROMYALGIA 60
288 SWOLLEN TONGUE 60
289 DEEP VEIN THROMBOSIS 59
290 DISEASE PROGRESSION 59
291 HEPATIC FUNCTION ABNORMAL 59
292 POOR QUALITY SLEEP 59
293 ROAD TRAFFIC ACCIDENT 59
294 STAPHYLOCOCCAL INFECTION 59
295 URINARY RETENTION 59
296 AGGRESSION 58
297 CONJUNCTIVITIS 58
298 DEVICE ISSUE 58
299 EAR PAIN 58
300 ILL-DEFINED DISORDER 58
301 INJECTION SITE RASH 58
302 BLOOD CREATININE INCREASED 57
303 DRUG EFFECT INCOMPLETE 57
304 PANCYTOPENIA 57
305 SKIN DISCOLOURATION 57
306 ACCIDENTAL OVERDOSE 56
307 ARTHROPATHY 56
308 FACE OEDEMA 56
309 LIMB DISCOMFORT 56
310 RESPIRATORY DISORDER 56
311 BRAIN FOG 55
312 MIDDLE INSOMNIA 55
313 MYOCARDIAL INFARCTION 55
314 ORAL HERPES 55
315 PANIC ATTACK 55
316 HYPOKALAEMIA 54
317 NIGHT SWEATS 54
318 PRODUCT DOSE OMISSION 54
319 PRODUCT SUBSTITUTION ISSUE 54
320 PRURITUS GENERALISED 54
321 CROHN^S DISEASE 53
322 DRUG EXPOSURE DURING PREGNANCY 53
323 EYE DISORDER 53
324 HEAD INJURY 53
325 MULTIPLE SCLEROSIS RELAPSE 53
326 RESPIRATORY TRACT CONGESTION 53
327 COGNITIVE DISORDER 52
328 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52
329 GASTROINTESTINAL HAEMORRHAGE 52
330 HYPOTHYROIDISM 52
331 SEDATION 52
332 SKIN DISORDER 52
333 CYSTITIS 51
334 MALIGNANT NEOPLASM PROGRESSION 51
335 CANDIDA INFECTION 50
336 NASAL DRYNESS 50
337 NERVOUSNESS 50
338 NEURALGIA 50
339 PHARYNGITIS 50
340 PSORIATIC ARTHROPATHY 50
341 THROAT TIGHTNESS 50
342 ANGER 49
343 DRY THROAT 49
344 FEBRILE NEUTROPENIA 49
345 RESTLESSNESS 49
346 SKIN BURNING SENSATION 49
347 SKIN HAEMORRHAGE 49
348 THERAPY NON-RESPONDER 49
349 ABNORMAL BEHAVIOUR 48
350 HYPOXIA 48
351 INJECTION SITE URTICARIA 48
352 SKIN IRRITATION 48
353 TREATMENT NONCOMPLIANCE 48
354 WHITE BLOOD CELL COUNT INCREASED 48
355 ACNE 47
356 CONTRAINDICATED PRODUCT ADMINISTERED 47
357 FOOT FRACTURE 47
358 HANGOVER 47
359 PAIN IN JAW 47
360 RESPIRATORY FAILURE 47
361 COLITIS 46
362 HAEMOPTYSIS 46
363 PRE-EXISTING CONDITION IMPROVED 46
364 PRESCRIBED OVERDOSE 46
365 TYPE 2 DIABETES MELLITUS 46
366 CHOLELITHIASIS 45
367 CRYING 45
368 HEART RATE DECREASED 45
369 IRRITABLE BOWEL SYNDROME 45
370 RED BLOOD CELL COUNT DECREASED 45
371 SUICIDE ATTEMPT 45
372 THIRST 45
373 ABORTION SPONTANEOUS 44
374 DERMATITIS 44
375 DYSKINESIA 44
376 GASTRITIS 44
377 HAEMATOCHEZIA 44
378 INTERVERTEBRAL DISC PROTRUSION 44
379 RENAL DISORDER 44
380 DEVICE MALFUNCTION 43
381 DISORIENTATION 43
382 ELECTROCARDIOGRAM QT PROLONGED 43
383 INFUSION SITE PRURITUS 43
384 PULMONARY OEDEMA 43
385 SCRATCH 43
386 TASTE DISORDER 43
387 CARDIAC FAILURE CONGESTIVE 42
388 EPILEPSY 42
389 MENTAL DISORDER 42
390 PANCREATITIS 42
391 PHARYNGITIS STREPTOCOCCAL 42
392 BRADYCARDIA 41
393 DELIRIUM 41
394 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 41
395 PRODUCT ADMINISTRATION INTERRUPTED 41
396 RESTLESS LEGS SYNDROME 41
397 RHINITIS 41
398 RHINITIS ALLERGIC 41
399 ERYTHEMA MULTIFORME 40
400 MUSCLE TIGHTNESS 40
401 RETCHING 40
402 WOUND 40
403 BACK DISORDER 39
404 HYPOACUSIS 39
405 INJECTION SITE MASS 39
406 SKIN LESION 39
407 SPEECH DISORDER 39
408 TREATMENT FAILURE 39
409 DIVERTICULITIS 38
410 LIGAMENT SPRAIN 38
411 SEPTIC SHOCK 38
412 SKIN ULCER 38
413 JOINT STIFFNESS 37
414 SECRETION DISCHARGE 37
415 BLOOD SODIUM DECREASED 36
416 BREAST CANCER 36
417 DRUG EFFECT DECREASED 36
418 EYELID OEDEMA 36
419 LARYNGITIS 36
420 MOOD ALTERED 36
421 NASAL POLYPS 36
422 SLUGGISHNESS 36
423 DEPRESSED LEVEL OF CONSCIOUSNESS 35
424 DRUG DEPENDENCE 35
425 DRUG WITHDRAWAL SYNDROME 35
426 NEEDLE ISSUE 35
427 RIB FRACTURE 35
428 SPINAL OSTEOARTHRITIS 35
429 TOXICITY TO VARIOUS AGENTS 35
430 DEAFNESS 34
431 EAR DISCOMFORT 34
432 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34
433 HEART RATE IRREGULAR 34
434 INCREASED APPETITE 34
435 INJECTION SITE HAEMORRHAGE 34
436 JAUNDICE 34
437 KIDNEY INFECTION 34
438 KNEE ARTHROPLASTY 34
439 LOCALISED INFECTION 34
440 MULTIPLE SCLEROSIS 34
441 SKIN LACERATION 34
442 BLOOD PRESSURE FLUCTUATION 33
443 DYSARTHRIA 33
444 FEEDING DISORDER 33
445 FOOD ALLERGY 33
446 PALLOR 33
447 PNEUMONIA ASPIRATION 33
448 PROCEDURAL PAIN 33
449 SCIATICA 33
450 BLOOD ALKALINE PHOSPHATASE INCREASED 32
451 BLOOD PRESSURE ABNORMAL 32
452 CARDIAC ARREST 32
453 EYE DISCHARGE 32
454 FEELING COLD 32
455 FEELING JITTERY 32
456 GLOSSODYNIA 32
457 GOUT 32
458 HEPATIC STEATOSIS 32
459 HIATUS HERNIA 32
460 INFUSION SITE DISCHARGE 32
461 JOINT INJURY 32
462 PARAESTHESIA ORAL 32
463 PRODUCT PRESCRIBING ISSUE 32
464 PRODUCT USE COMPLAINT 32
465 RASH MACULO-PAPULAR 32
466 ROTATOR CUFF SYNDROME 32
467 SCAR 32
468 WEIGHT FLUCTUATION 32
469 BLOOD CREATINE PHOSPHOKINASE INCREASED 31
470 CONVULSION 31
471 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31
472 FOETAL EXPOSURE DURING PREGNANCY 31
473 HYPONATRAEMIA 31
474 IMPAIRED HEALING 31
475 INTENTIONAL OVERDOSE 31
476 INTESTINAL OBSTRUCTION 31
477 LOWER RESPIRATORY TRACT INFECTION 31
478 POOR VENOUS ACCESS 31
479 PULMONARY HYPERTENSION 31
480 RASH GENERALISED 31
481 SOMNAMBULISM 31
482 ADRENAL INSUFFICIENCY 30
483 AGEUSIA 30
484 BACTERIAL INFECTION 30
485 BLOOD BILIRUBIN INCREASED 30
486 DEVICE DISLOCATION 30
487 DYSSTASIA 30
488 ERUCTATION 30
489 EXPIRED PRODUCT ADMINISTERED 30
490 HAEMORRHOIDS 30
491 HYPERLIPIDAEMIA 30
492 IMPAIRED WORK ABILITY 30
493 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 30
494 INFUSION SITE HAEMORRHAGE 30
495 LABORATORY TEST ABNORMAL 30
496 MUSCULOSKELETAL DISCOMFORT 30
497 NASAL DISCOMFORT 30
498 PARANASAL SINUS DISCOMFORT 30
499 RHABDOMYOLYSIS 30
500 TOOTHACHE 30
501 CLOSTRIDIUM DIFFICILE INFECTION 29
502 DEVICE DELIVERY SYSTEM ISSUE 29
503 EATING DISORDER 29
504 FOOT DEFORMITY 29
505 GAIT INABILITY 29
506 HIP FRACTURE 29
507 INFUSION SITE BRUISING 29
508 LIVER FUNCTION TEST ABNORMAL 29
509 LIVER INJURY 29
510 MAST CELL ACTIVATION SYNDROME 29
511 MOVEMENT DISORDER 29
512 PHARYNGEAL OEDEMA 29
513 PHOTOSENSITIVITY REACTION 29
514 PRODUCT TASTE ABNORMAL 29
515 TRANSIENT ISCHAEMIC ATTACK 29
516 CARPAL TUNNEL SYNDROME 28
517 COLITIS ULCERATIVE 28
518 DISABILITY 28
519 FAECES DISCOLOURED 28
520 GALLBLADDER DISORDER 28
521 HYPOPHAGIA 28
522 IMPAIRED GASTRIC EMPTYING 28
523 INCORRECT PRODUCT ADMINISTRATION DURATION 28
524 INITIAL INSOMNIA 28
525 MOOD SWINGS 28
526 MOUTH SWELLING 28
527 MUSCLE TWITCHING 28
528 ORAL CANDIDIASIS 28
529 OSTEOPENIA 28
530 PRODUCT STORAGE ERROR 28
531 RENAL FAILURE ACUTE 28
532 SINUS HEADACHE 28
533 STEVENS-JOHNSON SYNDROME 28
534 URINARY INCONTINENCE 28
535 AUTOIMMUNE DISORDER 27
536 BRONCHOSPASM 27
537 DRUG DOSE OMISSION BY DEVICE 27
538 END STAGE RENAL DISEASE 27
539 LOWER LIMB FRACTURE 27
540 MENTAL IMPAIRMENT 27
541 ORAL PAIN 27
542 OROPHARYNGEAL DISCOMFORT 27
543 PETECHIAE 27
544 PREGNANCY 27
545 PRODUCT PACKAGING ISSUE 27
546 RASH PAPULAR 27
547 THERAPEUTIC PRODUCT EFFECT DELAYED 27
548 TOOTH DISORDER 27
549 TOXIC EPIDERMAL NECROLYSIS 27
550 ANHEDONIA 26
551 ANKLE FRACTURE 26
552 CHROMATURIA 26
553 EOSINOPHIL COUNT INCREASED 26
554 HEPATITIS 26
555 HYPOAESTHESIA ORAL 26
556 IMPAIRED DRIVING ABILITY 26
557 PAIN OF SKIN 26
558 PULMONARY ARTERIAL HYPERTENSION 26
559 PURPURA 26
560 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26
561 THYROID DISORDER 26
562 ALOPECIA AREATA 25
563 ANGINA PECTORIS 25
564 ANOSMIA 25
565 APHASIA 25
566 DEMENTIA 25
567 DEVICE DIFFICULT TO USE 25
568 EMOTIONAL DISORDER 25
569 EOSINOPHILIA 25
570 EYE INFECTION 25
571 HYPERGLYCAEMIA 25
572 INFUSION SITE EXTRAVASATION 25
573 MUSCULOSKELETAL CHEST PAIN 25
574 OBESITY 25
575 ORAL DISCOMFORT 25
576 PNEUMONIA BACTERIAL 25
577 PRODUCT DISPENSING ERROR 25
578 RESPIRATORY DISTRESS 25
579 SKIN SWELLING 25
580 SKIN WEEPING 25
581 VITAMIN D DECREASED 25
582 VITAMIN D DEFICIENCY 25
583 AGRANULOCYTOSIS 24
584 BLOOD IRON DECREASED 24
585 BODY TEMPERATURE INCREASED 24
586 CEREBRAL INFARCTION 24
587 CHOKING 24
588 COVID-19 PNEUMONIA 24
589 DEVICE DEFECTIVE 24
590 FULL BLOOD COUNT DECREASED 24
591 MOUTH ULCERATION 24
592 NERVE COMPRESSION 24
593 PELVIC PAIN 24
594 PRESCRIBED UNDERDOSE 24
595 PRODUCT PHYSICAL ISSUE 24
596 PRODUCT PREPARATION ERROR 24
597 SKIN INFECTION 24
598 TENDERNESS 24
599 TOOTH INFECTION 24
600 TOXIC SKIN ERUPTION 24
601 APHONIA 23
602 BLOOD GLUCOSE DECREASED 23
603 FEMUR FRACTURE 23
604 GASTRIC DISORDER 23
605 GASTROENTERITIS 23
606 IMMUNODEFICIENCY 23
607 LYMPHOEDEMA 23
608 MEDICATION ERROR 23
609 NOCTURIA 23
610 POST PROCEDURAL COMPLICATION 23
611 PSEUDOMONAS INFECTION 23
612 PULMONARY MASS 23
613 UPPER LIMB FRACTURE 23
614 ACUTE RESPIRATORY FAILURE 22
615 BLOOD UREA INCREASED 22
616 CHOLECYSTECTOMY 22
617 COLD SWEAT 22
618 CYTOLYTIC HEPATITIS 22
619 DEVICE LEAKAGE 22
620 GASTROINTESTINAL INFECTION 22
621 HAIR TEXTURE ABNORMAL 22
622 HYPOGLYCAEMIA 22
623 KNEE OPERATION 22
624 MELAENA 22
625 NERVOUS SYSTEM DISORDER 22
626 OSTEONECROSIS 22
627 PERIORBITAL SWELLING 22
628 PLASMA CELL MYELOMA 22
629 RECTAL HAEMORRHAGE 22
630 SKIN CANCER 22
631 THINKING ABNORMAL 22
632 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 22
633 BACK INJURY 21
634 BLOOD TRIGLYCERIDES INCREASED 21
635 CHOLECYSTITIS 21
636 CHRONIC SINUSITIS 21
637 DECREASED ACTIVITY 21
638 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21
639 INTERVERTEBRAL DISC DEGENERATION 21
640 LIVER FUNCTION TEST INCREASED 21
641 PSYCHOMOTOR HYPERACTIVITY 21
642 SENSATION OF FOREIGN BODY 21
643 SENSITIVE SKIN 21
644 SKIN ABRASION 21
645 SPINAL OPERATION 21
646 TENDONITIS 21
647 TOOTH FRACTURE 21
648 VASCULITIS 21
649 ACUTE MYOCARDIAL INFARCTION 20
650 CONCUSSION 20
651 CYST 20
652 DEVICE BREAKAGE 20
653 DRUG TOLERANCE 20
654 EAR DISORDER 20
655 FEBRILE CONVULSION 20
656 HAEMATOCRIT DECREASED 20
657 HAEMATOMA 20
658 HEPATIC CIRRHOSIS 20
659 HYPERCHOLESTEROLAEMIA 20
660 HYPERURICAEMIA 20
661 IMMUNE SYSTEM DISORDER 20
662 INCORRECT DRUG ADMINISTRATION RATE 20
663 INFUSION SITE REACTION 20
664 LEUKOPENIA 20
665 MUSCLE STRAIN 20
666 NEOPLASM MALIGNANT 20
667 PARANOIA 20
668 PEMPHIGOID 20
669 PERIPHERAL COLDNESS 20
670 PRODUCT PRESCRIBING ERROR 20
671 SARS-COV-2 TEST POSITIVE 20
672 SINUS PAIN 20
673 SPINAL FRACTURE 20
674 TRANSAMINASES INCREASED 20
675 VAGINAL HAEMORRHAGE 20
676 VISUAL ACUITY REDUCED 20
677 WRIST FRACTURE 20
678 BIPOLAR DISORDER 19
679 BURSITIS 19
680 CHOLESTASIS 19
681 COMPLICATION ASSOCIATED WITH DEVICE 19
682 CONJUNCTIVITIS ALLERGIC 19
683 DENTAL CARIES 19
684 FEAR 19
685 FOLLICULITIS 19
686 GLAUCOMA 19
687 HORDEOLUM 19
688 HUNGER 19
689 HYSTERECTOMY 19
690 ILEUS 19
691 INFUSION SITE RASH 19
692 LUNG NEOPLASM MALIGNANT 19
693 NASAL PRURITUS 19
694 NODULE 19
695 PNEUMONITIS 19
696 PRODUCT DISTRIBUTION ISSUE 19
697 REBOUND EFFECT 19
698 RENAL CYST 19
699 RESPIRATION ABNORMAL 19
700 SHOCK 19
701 SKIN PLAQUE 19
702 SYNOVITIS 19
703 TEMPERATURE INTOLERANCE 19
704 TENDON RUPTURE 19
705 THERAPEUTIC RESPONSE DELAYED 19
706 TOOTH ABSCESS 19
707 TUBULOINTERSTITIAL NEPHRITIS 19
708 ACTIVITIES OF DAILY LIVING IMPAIRED 18
709 AFFECTIVE DISORDER 18
710 ARTHROPOD BITE 18
711 BASAL CELL CARCINOMA 18
712 BLADDER DISORDER 18
713 BLOOD URINE PRESENT 18
714 CHOLECYSTITIS CHRONIC 18
715 DEVICE USE ERROR 18
716 FEELING DRUNK 18
717 GASTRIC ULCER 18
718 GENERALISED ERYTHEMA 18
719 GLYCOSYLATED HAEMOGLOBIN INCREASED 18
720 HALLUCINATION, VISUAL 18
721 HEPATIC FAILURE 18
722 HIP ARTHROPLASTY 18
723 HYPERTHYROIDISM 18
724 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18
725 INTENTIONAL SELF-INJURY 18
726 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18
727 PAPULE 18
728 PLATELET COUNT INCREASED 18
729 PULMONARY FIBROSIS 18
730 SPUTUM DISCOLOURED 18
731 STREPTOCOCCAL INFECTION 18
732 ABORTION INDUCED 17
733 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 17
734 BLOOD CALCIUM DECREASED 17
735 BLOOD TEST ABNORMAL 17
736 BODY HEIGHT DECREASED 17
737 DIARRHOEA HAEMORRHAGIC 17
738 ENCEPHALOPATHY 17
739 EXOSTOSIS 17
740 FACIAL PAIN 17
741 FRACTURE 17
742 FRUSTRATION TOLERANCE DECREASED 17
743 GASTROINTESTINAL PAIN 17
744 HEPATOMEGALY 17
745 INJECTION SITE DISCOLOURATION 17
746 MUSCULOSKELETAL DISORDER 17
747 PANCREATITIS ACUTE 17
748 PAROSMIA 17
749 PELVIC FRACTURE 17
750 PRODUCT AVAILABILITY ISSUE 17
751 PYELONEPHRITIS 17
752 SCAB 17
753 SENSORY DISTURBANCE 17
754 SNORING 17
755 SUPRAVENTRICULAR TACHYCARDIA 17
756 SWELLING OF EYELID 17
757 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17
758 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16
759 ATELECTASIS 16
760 BLOOD POTASSIUM INCREASED 16
761 DEVICE INFUSION ISSUE 16
762 DEVICE RELATED INFECTION 16
763 ECONOMIC PROBLEM 16
764 ERYTHEMA OF EYELID 16
765 EYE INFLAMMATION 16
766 GINGIVITIS 16
767 HAND FRACTURE 16
768 HEAVY MENSTRUAL BLEEDING 16
769 HYPERKALAEMIA 16
770 HYPOKINESIA 16
771 INJECTION SITE WARMTH 16
772 LIP DRY 16
773 LYMPHOCYTE COUNT DECREASED 16
774 MYELOSUPPRESSION 16
775 PEMPHIGUS 16
776 PERICARDIAL EFFUSION 16
777 POLYARTHRITIS 16
778 PRODUCT ADMINISTRATION ERROR 16
779 PULMONARY CONGESTION 16
780 SJOGREN^S SYNDROME 16
781 ANAL INCONTINENCE 15
782 BOWEL MOVEMENT IRREGULARITY 15
783 BRONCHIECTASIS 15
784 CEREBRAL HAEMORRHAGE 15
785 CHOLANGITIS 15
786 CYANOSIS 15
787 DERMATITIS BULLOUS 15
788 DRUG ABUSE 15
789 DYSTONIA 15
790 EAR PRURITUS 15
791 ENURESIS 15
792 ERECTILE DYSFUNCTION 15
793 EUPHORIC MOOD 15
794 FREQUENT BOWEL MOVEMENTS 15
795 HEPATIC ENCEPHALOPATHY 15
796 HERNIA 15
797 HYPERVENTILATION 15
798 HYPOTONIA 15
799 INCORRECT DOSE ADMINISTERED BY DEVICE 15
800 INFUSION SITE INDURATION 15
801 INFUSION SITE MASS 15
802 INJECTION SITE VESICLES 15
803 INTERNATIONAL NORMALISED RATIO INCREASED 15
804 LOW BIRTH WEIGHT BABY 15
805 LUPUS-LIKE SYNDROME 15
806 MASS 15
807 MATERNAL EXPOSURE BEFORE PREGNANCY 15
808 MENSTRUATION IRREGULAR 15
809 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15
810 OBSTRUCTION 15
811 ORAL DISORDER 15
812 OTITIS MEDIA 15
813 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15
814 PLEURISY 15
815 PNEUMOTHORAX 15
816 PRODUCT COMPLAINT 15
817 PRODUCT ODOUR ABNORMAL 15
818 PROTEINURIA 15
819 RENAL INJURY 15
820 SLEEP DEFICIT 15
821 SYNOVIAL CYST 15
822 THERAPEUTIC PRODUCT EFFECT VARIABLE 15
823 THERAPY CHANGE 15
824 URINE OUTPUT DECREASED 15
825 VENTRICULAR TACHYCARDIA 15
826 WOUND INFECTION 15
827 ACCIDENT 14
828 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14
829 ADVERSE REACTION 14
830 APHTHOUS ULCER 14
831 AUTOIMMUNE THYROIDITIS 14
832 BLOOD LACTATE DEHYDROGENASE INCREASED 14
833 BLOOD MAGNESIUM DECREASED 14
834 BONE DENSITY DECREASED 14
835 CORONARY ARTERY DISEASE 14
836 CYSTIC FIBROSIS 14
837 CYTOMEGALOVIRUS INFECTION 14
838 DERMATITIS ALLERGIC 14
839 DERMATITIS EXFOLIATIVE 14
840 DIABETIC KETOACIDOSIS 14
841 DRUG ADMINISTRATION ERROR 14
842 EXTRASYSTOLES 14
843 EYE MOVEMENT DISORDER 14
844 FOETAL DEATH 14
845 GLOMERULAR FILTRATION RATE DECREASED 14
846 GLOSSITIS 14
847 HAEMORRHAGIC ANAEMIA 14
848 HEPATITIS CHOLESTATIC 14
849 LACTIC ACIDOSIS 14
850 LUNG INFECTION 14
851 LUNG INFILTRATION 14
852 MICTURITION URGENCY 14
853 MUSCLE RIGIDITY 14
854 NASAL OEDEMA 14
855 NEPHROGENIC ANAEMIA 14
856 NERVE INJURY 14
857 ORAL MUCOSAL BLISTERING 14
858 PARANASAL SINUS HYPERSECRETION 14
859 PERIPHERAL VENOUS DISEASE 14
860 PRODUCT PACKAGING QUANTITY ISSUE 14
861 RHINOVIRUS INFECTION 14
862 SENSITIVITY TO WEATHER CHANGE 14
863 SINUS OPERATION 14
864 SKIN WARM 14
865 SPINAL FUSION SURGERY 14
866 SPONDYLITIS 14
867 TARDIVE DYSKINESIA 14
868 TENDON DISORDER 14
869 THERAPY PARTIAL RESPONDER 14
870 VIRAL UPPER RESPIRATORY TRACT INFECTION 14
871 WRONG PRODUCT ADMINISTERED 14
872 ABDOMINAL PAIN LOWER 13
873 ACUTE SINUSITIS 13
874 ANKYLOSING SPONDYLITIS 13
875 BLEPHARITIS 13
876 BLOOD GLUCOSE ABNORMAL 13
877 BLOOD PRESSURE SYSTOLIC INCREASED 13
878 BREAST CANCER FEMALE 13
879 CARDIOMEGALY 13
880 CEREBRAL DISORDER 13
881 CHOKING SENSATION 13
882 COELIAC DISEASE 13
883 DEVICE EXPULSION 13
884 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13
885 DYSLIPIDAEMIA 13
886 ELECTROLYTE IMBALANCE 13
887 EMPHYSEMA 13
888 FOETAL MALFORMATION 13
889 HAEMOGLOBIN INCREASED 13
890 HAIR COLOUR CHANGES 13
891 HAIR GROWTH ABNORMAL 13
892 HAND DEFORMITY 13
893 HYPOCALCAEMIA 13
894 HYPOPHOSPHATAEMIA 13
895 INCONTINENCE 13
896 INFUSION SITE INFECTION 13
897 INJECTION SITE DISCOMFORT 13
898 INJECTION SITE INDURATION 13
899 INJECTION SITE INFLAMMATION 13
900 INJECTION SITE IRRITATION 13
901 INJECTION SITE NODULE 13
902 IRON DEFICIENCY ANAEMIA 13
903 JOINT DISLOCATION 13
904 JOINT RANGE OF MOTION DECREASED 13
905 LEUKOCYTOSIS 13
906 MALNUTRITION 13
907 METRORRHAGIA 13
908 MIDDLE EAR EFFUSION 13
909 MUSCLE DISORDER 13
910 OESOPHAGITIS 13
911 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 13
912 PRODUCT PREPARATION ISSUE 13
913 QUALITY OF LIFE DECREASED 13
914 RHEUMATOID FACTOR POSITIVE 13
915 ROSACEA 13
916 SALIVARY HYPERSECRETION 13
917 SCREAMING 13
918 SHOULDER OPERATION 13
919 SKIN HYPERPIGMENTATION 13
920 SPINAL DISORDER 13
921 TOOTH EXTRACTION 13
922 TOOTH LOSS 13
923 TUBERCULOSIS 13
924 TYPE 1 DIABETES MELLITUS 13
925 UNRESPONSIVE TO STIMULI 13
926 WALKING AID USER 13
927 ABASIA 12
928 ALLERGIC REACTION TO EXCIPIENT 12
929 AMENORRHOEA 12
930 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 12
931 AUTOIMMUNE HEPATITIS 12
932 BEDRIDDEN 12
933 BENIGN PROSTATIC HYPERPLASIA 12
934 BLOOD THYROID STIMULATING HORMONE INCREASED 12
935 BONE DISORDER 12
936 BONE MARROW FAILURE 12
937 BREAST MASS 12
938 CARDIAC FLUTTER 12
939 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12
940 COMPRESSION FRACTURE 12
941 CUTANEOUS VASCULITIS 12
942 DEVICE USE ISSUE 12
943 DRUG LEVEL DECREASED 12
944 EOSINOPHILIC OESOPHAGITIS 12
945 EYELID PAIN 12
946 FOREIGN BODY SENSATION IN EYES 12
947 FUNCTIONAL GASTROINTESTINAL DISORDER 12
948 HAEMORRHAGE SUBCUTANEOUS 12
949 HAIR DISORDER 12
950 HALLUCINATION, AUDITORY 12
951 HICCUPS 12
952 HOSPICE CARE 12
953 HYPERCALCAEMIA 12
954 INFUSION SITE WARMTH 12
955 INTRAOCULAR PRESSURE INCREASED 12
956 LYME DISEASE 12
957 MENTAL STATUS CHANGES 12
958 MOTION SICKNESS 12
959 MUSCLE SPASTICITY 12
960 MYOSITIS 12
961 NAIL GROWTH ABNORMAL 12
962 NONSPECIFIC REACTION 12
963 NOROVIRUS INFECTION 12
964 ONYCHOCLASIS 12
965 ORTHOSTATIC HYPOTENSION 12
966 OSTEOMYELITIS 12
967 OVARIAN CYST 12
968 POST PROCEDURAL INFECTION 12
969 PRODUCT ADHESION ISSUE 12
970 PRODUCT RESIDUE PRESENT 12
971 PULMONARY ALVEOLAR HAEMORRHAGE 12
972 PULMONARY THROMBOSIS 12
973 RASH PUSTULAR 12
974 SINUS TACHYCARDIA 12
975 SKIN REACTION 12
976 SLEEP TERROR 12
977 SPINAL STENOSIS 12
978 SUNBURN 12
979 THYROID FUNCTION TEST ABNORMAL 12
980 THYROID MASS 12
981 TONGUE DISORDER 12
982 TRISOMY 18 12
983 UPPER RESPIRATORY TRACT INFLAMMATION 12
984 URINARY HESITATION 12
985 VITREOUS FLOATERS 12
986 ANAL ABSCESS 11
987 ANAPHYLACTOID REACTION 11
988 APPLICATION SITE PAIN 11
989 ATYPICAL PNEUMONIA 11
990 BLINDNESS TRANSIENT 11
991 BLOOD ALBUMIN DECREASED 11
992 BRAIN OEDEMA 11
993 CENTRAL NERVOUS SYSTEM LESION 11
994 CHEILITIS 11
995 COLON CANCER 11
996 CONJUNCTIVAL HYPERAEMIA 11
997 DEVICE OCCLUSION 11
998 DRUG TOLERANCE DECREASED 11
999 ENTERITIS INFECTIOUS 11